An Issue of Dependence: Implications From the Aliskiren in the Evaluation of Proteinuria in Diabetes (AVOID) Trial

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2009-02, Vol.11 (2), p.89-93
Hauptverfasser:	Riche, Daniel M., Minor, Deborah S., Holdiness, Amber S., East, Honey E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Amides - administration & dosage Angiotensin II Type 1 Receptor Blockers - administration & dosage Angiotensin-Converting Enzyme Inhibitors - administration & dosage Antihypertensive Agents - administration & dosage Clinical Trials as Topic Commentaries Diabetes Mellitus, Type 2 - complications Diabetic Nephropathies - complications Diabetic Nephropathies - prevention & control Drug Therapy, Combination Evidence-Based Medicine Fumarates - administration & dosage Humans Hypertension - complications Hypertension - drug therapy Proteinuria - etiology Proteinuria - prevention & control Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!